FDA: OTC Inhalants Touted to Boost Energy Primarily Contain Ammonia

FDA HQ
Credit: Getty Images.
The FDA issued a warning letter to Nose Slap LLC for marketing these unapproved drugs.

Consumers are being warned not to purchase or use Nose Slap or Soul Slap as these products primarily contain ammonia. These unapproved products are administered through inhalation and are being marketed as over-the-counter stimulants to promote alertness and boost energy.

According to the Food and Drug Administration (FDA), the inhalation of ammonia can result in coughing, airway constriction, and immediate irritation of the eyes, nose, and throat. Adverse events such as shortness of breath, seizures, migraines, vomiting, diarrhea, and fainting have been reported after using the Nose Slap and Soul Slap products. 

Health care providers and consumers are encouraged to report adverse events related to these unapproved products to the FDA’s MedWatch Adverse Event Reporting program.

References:

FDA warns consumers to not purchase or use Nose Slap and Soul Slap products marketed for alertness and energy boosting. News release. US Food and Drug Administration. Accessed May 1, 2023. https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-consumers-not-purchase-or-use-nose-slap-and-soul-slap-products-marketed-alertness-and.